Neurocrine Biosciences Inc.

NBIX·NASDAQ·$155.73Share Price as of 11/2·$16BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2607/31/26 10-QQ1 ended 03/31/2605/05/26 10-KFY 202502/11/26 10-QQ3 ended 09/30/2510/28/25 10-QQ2 ended 06/30/2507/30/25

Disclosures

8-KCurrent report09/28/26 8-K/ACurrent report (amended)07/31/26 8-KCurrent report07/30/26 8-KCurrent report05/28/26 8-KCurrent report05/18/26

Prospectuses and Registrations

S-8Registration of securities for employees07/31/26 S-8Registration of securities for employees05/21/25 S-8 POSPost-effective amendment (S-8)05/21/25 S-8 POSPost-effective amendment (S-8)05/21/25 S-8 POSPost-effective amendment (S-8)05/21/25

Proxies

DEF 14ADefinitive proxy04/15/26 DEFA14AAdditional proxy materials04/15/26 DEF 14ADefinitive proxy04/09/25 DEFA14AAdditional proxy materials04/09/25 DEF 14ADefinitive proxy04/10/24

Ownership

144Proposed sale of securities10/30/26 Form 3Initial insider ownership10/07/26 Form 4Insider transaction09/15/26 Form 4Insider transaction09/15/26 Form 4Insider transaction09/15/26

Other

SC TO-T/ASC TO-T/A04/28/26 SC TO-TThird party tender offer04/20/26 ARSAnnual report to shareholders04/15/26 SC TO-CSC TO-C04/07/26 SC TO-CSC TO-C04/06/26